Congresses and Conferences Committee
Hybrid meeting during 2022 WorldLab Seoul
L/R - T/B
W.H.Fang, Member; A. Buňo Soto, Member; A.Sepici Dincel, Corresponding Member; S.Robinson, Corresponding Member; M.Blanes, Member; H.Martin, Corresponding Member; P. Laitinen, Chair
Last picture L/R
S.Cardinale, IFCC Office; P.Laitinen, Chair; H.Martin, Corresponding Member; M.Blanes, Member
Name | Position | Country | Term | Time in Office |
P.Laitinen | Chair | FI | 1st | 2021 01 - 2023 12 |
M. Blanes Gonzales | Member | PY | 2nd | 2021 01 - 2023 12 |
A. Buňo Soto | Member | ES | 1st | 2021 01 -2023 12 |
W.H. Fang | Member | TW | 1st | 2023 01 - 2025 12 |
V. Palicka | Member | CZ | 1st | 2023 01 - 2025 12 |
C. Jackson | Corporate Member | US | 2nd | 202101 - 2023 12 |
B.K.T.P. Dayanath | Corresponding Member | LK | ||
O.Deli Vazquez Paulino | Corresponding Member | MX | ||
P. Jannetto | Corresponding Member | US | ||
J. Kumalawati | Corresponding Member | ID | ||
I. Lukic | Corresponding Member | HR | ||
H. Martin | Corresponding Member | AU | ||
G. Panahi | Corresponding Member | IR | ||
S. Robinson | Corresponding Member | UK | ||
A.Sepici Dincel | Corresponding Member | TR | ||
R.R. Sinha | Corresponding Member | IN | ||
C. Tsatsanis | Corresponding Member | GR | ||
P.Datta | Corresponding Member | Siemens Healthineers |
The Committee on Congresses and Conferences was established in December 2007, and is the continuation of the former Congress and Conference Division (CCD) which was founded in 1996, but with an expanded charter and responsibilities. The C-CC has the major administrative and managerial responsibility within the IFCC for all meetings coordinated by the IFCC.
The mission of the C-CC is to provide general administration and management of all IFCC meeting activities (congresses, conferences, and symposia) and to review applications for IFCC auspices from non-IFCC conferences requesting such sponsorship.
The C-CC supports and promotes Clinical Laboratory Sciences through congresses, conferences, specialised meetings, and other professional meetings. The C-CC Works closely with the organisers of the various IFCC related conferences to ensure that they achieve organisational and professional excellence.
The C-CC formulates and updates as required the guidelines, procedures and practices for IFCC-designated meetings and also monitors compliance throughout the planning and organizational stages. The C-CC assists the organizing groups in the administration and promotion of conferences, and helps these conferences obtain support, and achieve financial efficiency in the various economical aspects of their meetings.
The C-CC reviews all existing meeting guidelines every three years to ensure their continued applicability and will write new guidelines for those meetings not covered by existing procedures.
The C-CC maintains a current 5-year listing of congresses and conferences of professional interest to the members of the IFCC, including both IFCC related conferences and those outside the IFCC. This allows members to be aware of these meetings and allows potential conference organisers to plan the dates of their meetings with care.
The C-CC designates as official IFCC approved meetings those conferences that conform to the requirements of the IFCC as a professional organisation, in order to promote the field of clinical laboratory sciences and protect the interests of the IFCC. Within the framework of the IFCC designated meetings, the C-CC will promote the IFCC and its functional units and discuss the possibility of integration of IFCC units and members in the programme of the conference.
The C-CC assists in expanding the list of IFCC Master Conferences on specific scientific and educational topics and promotes the leadership role of the IFCC in the field of Clinical Laboratory Sciences.
I | Amsterdam (NL) | 1954 |
II | New York (US) | 1956 |
III | Stockholm (SE) | 1957 |
IV | Edinburgh (UK) | 1960 |
V | Detroit (US) | 1963 |
VI | Munich (DE) | 1966 |
VII | Geneva/Evian (CH/FR) | 1969 |
VIII | Copenhagen (DK) | 1972 |
IX | Toronto (CA) | 1975 |
X | Mexico City (MX) | 1978 |
XI | Vienna (AT) | 1981 |
XII | Rio de Janeiro (BR) | 1984 |
XIII | The Hague (NL) | 1987 |
XIV | San Francisco (US) | 1990 |
XV | Melbourne (AU) | 1993 |
XVI | London (UK) | 1996 |
XVII | Florence (IT) | 1999 |
XVIII | Kyoto (JP) | 2002 |
XIX | Orlando (US) | 2005 |
XX | Fortaleza (BR) | 2008 |
XXI | Berlin (DE) | 2011 |
XXII | Istanbul (TR) | 2014 |
XXIII | Durban (ZA) | 2017 |
XXIV | Seoul (KR) | 2022 |
XXV | Rome (IT) | 2023 |
XXVI | Dubai (UAE) | 2024 |
III | Singapore (SG) | 1986 |
IV | Hong Kong (HK) | 1988 |
V | Kobe (JP) | 1991 |
VI | Melbourne (AU) | 1993 |
VII | Bangkok (TH) | 1995 |
VIII | Kuala Lumpur (MY) | 1998 |
IX | New Dehli (IN) | 2001 |
X | Perth (AU) | 2004 |
XI | Beijing (CN) | 2007 |
XII | Seoul (KR) | 2010 |
XIII | Bali (ID) | 2013 |
XIV | Taiwan (TW) | 2016 |
XV | Jaipur (IN) | 2019 |
XVI | Seoul (KR) | 2022 |
XVI | Sydney (AU) | 2024 |
I | Munich (DE) | 1974 |
II | Prague (CZ) | 1976 |
III | Brighton (UK) | 1979 |
IV | Vienna (AT) | 1981 |
V | Budapest (HU) | 1983 |
VI | Jerusalem (IL) | 1985 |
VII | Den Hague (NL) | 1987 |
VIII | Milan (IT) | 1989 |
IX | Crakow (PL) | 1991 |
X | Nice (FR) | 1993 |
XI | Tampere (FI) | 1995 |
XII | Basel (CH) | 1997 |
XIII | Florence (IT) | 1999 |
XIV | Prague (CZ) | 2001 |
XV | Barcelona (ES) | 2003 |
XVI | Glasgow (UK) | 2005 |
XVII | Amsterdam (NL) | 2007 |
XVIII | Innsbruck (AT) | 2009 |
XIX | Berlin (DE) (with ICCCLM 2011) | 2011 |
XX | Milan (IT) | 2013 |
XXI | Paris (FR) | 2015 |
XXII | Athens (GR) | 2017 |
XXIII | Barcelona (ES) | 2019 |
XXIV | Munich | 2021 |
XXV |
Rome |
2023 |
S.to Domingo (DO) | 1991 |
Acapulco (MX) | 1993 |
Buenos Aires (AR) | 1995 |
Caracas (VE) | 1997 |
Puerto Rico (PR) | 1999 |
Florianopolis (BR) | 2001 |
San José (CR) | 2003 |
Asunciòn (PA) | 2006 |
Panama (PAN) | 2007 |
Santiago (CL) | 2010 |
Punta Cana (DO) | 2011 |
Lima (PE) | 2013 |
Quito (EC) | 2015 |
Punta del Este (UY) | 2017 |
Panama (PA) | 2019 |
Leon (MX) | 2022 |
Cairo (EG) | 1974 |
Faihaa (SY) | 1976 |
Cairo (EG) | 1980 |
Cairo (EG) | 1983 |
Cairo (EG) | 1986 |
Tunis (TN) | 1991 |
Faihaa (SY) | 1994 |
Amman (JO) | 1997 |
Rabat (MA) | 2000 |
Monastir (TU) | 2004 |
Damascus (SY) | 2006 |
Beirut (LB) | 2009 |
Marrakesh (MA) | 2012 |
Karthoum (SD) | 2015 |
Palestine (PS) | 2018 |
Broumana (LB) | 2022 |
Ibadan (NG) | 2009 |
Nairobi (KE) | 2011 |
Harare (ZW) | 2015 |
Marrakesh (MA) | 2019 |
Lusaka (ZM) | 2021 |
2021 - Virtual IFCC Global Conference on COVID-19
The 2020 pandemic has highlighted the critical role of clinical laboratory medicine. Clinical laboratory professionals has playd a vital role in the diagnosis of SARS-CoV-2 infection, serological monitoring of individuals with past SARS-CoV-2 infection, and biochemical monitoring of hospitalized patients with COVID-19.
IFCC has established a Taskforce on COVID-19 to provide updates on epidemiology, pathogenesis, and diagnostics of COVID-19, as well as to develop practical recommendations for diagnostic testing and patient monitoring. Since establishment, the Taskforce has maintained an online Information Guide on COVID-19, which can be found on the IFCC website. This guide is updated biweekly, presenting the latest evidence on COVID-19.
IFCC has hosted a virtual IFCC Global Conference on COVID-19 on February 15-17, 2021. This virtual conference has brought leading experts around the world together to present the latest advances in COVID-19 diagnostics and therapeutics. The theme of this conference was the Critical Role of Clinical Laboratories in the COVID-19 Pandemic.
The program, included ten scientific symposia, covering physiology, diagnostics, therapeutics, and technology, as well as special presentations on the global response to COVID-19 in Africa, Asia-Pacific, Europe, Latin America, Arab Federation, and North America. There was an industry panel with presentations from industry leaders on the latest IVD innovations and twelve educational industry workshops. Young investigators had their own forum with presentations from young scientists worldwide. There was also an opportunity for scientific e-posters and virtual industry exhibits.
Conference organizing committee
Khosrow Adeli, CA (Chair)
Sergio Bernardini, IT
Andrea Horvath, AU
David Koch, US
Giuseppe Lippi, IT
Tomris Ozben, TR
Cheng-Bin Wang, CN
Corporate Representatives:
Rolf Hinzmann, Roche Diagnostics
Patricia Ravalico, Abbott Diagnostics
Regional Federation Representatives:
Rosa Sierra-Amor (COLABIOCLI)
Ana-Maria Simundic (EFLM)
Ann Gronowski (NAFCC)
Rajiv Erasmus (AFCC)
Sunil Kumar Sethi (APFCB)
Osama Najjar (AFCB)
Conference Organizing Secretariat (MZ Congressi):
Stefano Montalbetti
Terms of Reference
Recent Conferences:
VII | 1999 | Biochemical markers for myocardial damage |
VIII | 2001 | Biochemical markers of autoimmune disease |
IX | 2003 | Nucleic acid markers for bacterial and viral infections in intensive care |
X | 2005 | Diabetes and cardiovascular disease |
XI | 2008 | Markers of kidney disease |
XII | 2010 | Novel biomarkers: from discovery to clinical application |
XIII | 2012 | Vitamin D in health and disease |
XIV | 2014 | Women's Health |
XV | 2016 | Biomarkers in the Diagnosis and Monitoring of Cancer |
The following documents have been prepared by the C-CC.
Aim
The aim of the IFCC General Conference is to convene all the IFCC functional units at one time and location, in order to discuss present activities and projects, and to plan and decide on future actions of the organization.
Responsibilities
Time and Venue
Scope
Conferences:
I | Rungestedgaard (DK) | 1981 |
II | Rungestedgaard (DK) | 1984 |
III | Monza (IT) | 1988 |
IV | Pont-à-Mousson (FR) | 1992 |
V | Leipzig (DE) | 1995 |
VI | Sevilla (ES) | 1998 |
VII | Dubrovnik (HR) | 2001 |
VIII | Sousse (TN) | 2004 |
IX | Antalya (TR) | 2008 |
X | Corfu (GR) | 2010 |
XI | Kuala Lumpur (MY) | 2012 |
XII | Madrid (ES) | 2016 |
XIII | Budapest (HU) | 2018 |
Chair:
Prof. Paivi LAITINEN
Adjunct Professor
Oulu
FINLAND
paivi.h.laitinen@hotmail.fi
Members:
Dr. Antonio BUÑO SOTO
Department of Laboratory Medicine
University Hospital La Paz
Paseo de la Castellana 261
28046 Madrid
SPAIN
e-mail:antoniobuno@gmail.com
Prof. Montserrat BLANES GONZALES
Dept.of Medical Education and Research
Central Hospital
Paraguayan Social Security Institute
Av.da Sacramento y Dr Peña
1209, Asuncion, Paraguay
e-mail: mblanes@ips.gov.py
Prof. Woei-horng FANG
Dept of Clinical Laboratory Sciences
and Medical Biotechnology
National Taiwan University
College of Medicine
#7 Chung-Shan South Road
Taipei 100-02,TAIWAN
e-mail: whfang@ntu.edu.tw
Prof. Vladimir PALICKA
Institute of Clinical Biochemistry and Diagnostics
Charles University,
University Hospital Hradec Kralové,
Sokolska 581, 500 05 Hradec Kralové
Czech Republic
e-mail: palicka@lfhk.cuni.cz
Corporate Member:
Mrs. Cheryl JACKSON
Global Marketing Technology and Sales Education
Beckman Coulter Diagnostics
200 South Kraemer Boulevard
Brea, CA 92821, USA
e-mail: cbjackson@beckman.com
Corresponding Members nominated by National Societies:
Ms. Helen MARTIN
AUSTRALIA
e-mail: Helen.Martin2@sa.gov.au
Ms. Iva LUKIC
CROATIA
e-mail:iva.lukic@kbco.hr
Prof. Christos TSATSANIS
GREECE
e-mail:tsatsani@uoc.gr
Dr. Rajiv Ranjan SINHA
INDIA
e-mail:kpsacbi@yahoo.co.in
Dr. Ghodratollah PANAHI
IRAN
e-mail:ghpanahi@sina.tums.ac.ir
Dr. July KUMALAWATI
INDONESIA
e-mail:julykw@gmail.com
Olga Deli VAZQUEZ PAULINO
MEXICO
e-mail:vinculacionifcc@conaquic.com
Dr. B.K.T.P. DAYANATH
SRI LANKA
e-mail:dayanath1@yahoo.com
Dr. Aylin SEPICI DINCEL
TURKEY
email: asepicidincel@gmail.com
Dr. Sarah ROBINSON
UK
e-mail: sarah.robinson2@uhnm.nhs.uk
Dr. Paul JANNETTO
US
e-mail: Jannetto.Paul@mayo.edu
Corresponding Members nominated by Corporate Members:
Dr. Pradip Datta
SIEMENS Heathineers
e-mail: pradip.datta@siemens-healthineers.com